Cargando…
Method for estimating disease risk from microbiome data using structural equation modeling
The relationship between the human gut microbiota and disease is of increasing scientific interest. Previous investigations have focused on the differences in intestinal bacterial abundance between control and affected groups to identify disease biomarkers. However, different types of intestinal bac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909428/ https://www.ncbi.nlm.nih.gov/pubmed/36778866 http://dx.doi.org/10.3389/fmicb.2023.1035002 |
_version_ | 1784884575164432384 |
---|---|
author | Tokuno, Hidetaka Itoga, Tatsuya Kasuga, Jumpei Okuma, Kana Hasuko, Kazumi Masuyama, Hiroaki Benno, Yoshimi |
author_facet | Tokuno, Hidetaka Itoga, Tatsuya Kasuga, Jumpei Okuma, Kana Hasuko, Kazumi Masuyama, Hiroaki Benno, Yoshimi |
author_sort | Tokuno, Hidetaka |
collection | PubMed |
description | The relationship between the human gut microbiota and disease is of increasing scientific interest. Previous investigations have focused on the differences in intestinal bacterial abundance between control and affected groups to identify disease biomarkers. However, different types of intestinal bacteria may have interacting effects and thus be considered biomarker complexes for disease. To investigate this, we aimed to identify a new kind of biomarker for atopic dermatitis using structural equation modeling (SEM). The biomarkers identified were latent variables, which are complex and derived from the abundance data for bacterial marker candidates. Groups of females and males classified as healthy participants [normal control (NC) (female: 321 participants, male: 99 participants)], and patients afflicted with atopic dermatitis only [AS (female: 45 participants, male: 13 participants)], with atopic dermatitis and other diseases [AM (female: 75 participants, male: 34 participants)], and with other diseases but without atopic dermatitis [OD (female: 1,669 participants, male: 866 participants)] were used in this investigation. The candidate bacterial markers were identified by comparing the intestinal microbial community compositions between the NC and AS groups. In females, two latent variables (lv) were identified; for lv1, the associated components (bacterial genera) were Alistipes, Butyricimonas, and Coprobacter, while for lv2, the associated components were Agathobacter, Fusicatenibacter, and Streptococcus. There was a significant difference in the lv2 scores between the groups with atopic dermatitis (AS, AM) and those without (NC, OD), and the genera identified for lv2 are associated with the suppression of inflammatory responses in the body. A logistic regression model to estimate the probability of atopic dermatitis morbidity with lv2 as an explanatory variable had an area under the curve (AUC) score of 0.66 when assessed using receiver operating characteristic (ROC) analysis, and this was higher than that using other logistic regression models. The results indicate that the latent variables, especially lv2, could represent the effects of atopic dermatitis on the intestinal microbiome in females. The latent variables in the SEM could thus be utilized as a new type of biomarker. The advantages identified for the SEM are as follows: (1) it enables the extraction of more sophisticated information when compared with models focused on individual bacteria and (2) it can improve the accuracy of the latent variables used as biomarkers, as the SEM can be expanded. |
format | Online Article Text |
id | pubmed-9909428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99094282023-02-10 Method for estimating disease risk from microbiome data using structural equation modeling Tokuno, Hidetaka Itoga, Tatsuya Kasuga, Jumpei Okuma, Kana Hasuko, Kazumi Masuyama, Hiroaki Benno, Yoshimi Front Microbiol Microbiology The relationship between the human gut microbiota and disease is of increasing scientific interest. Previous investigations have focused on the differences in intestinal bacterial abundance between control and affected groups to identify disease biomarkers. However, different types of intestinal bacteria may have interacting effects and thus be considered biomarker complexes for disease. To investigate this, we aimed to identify a new kind of biomarker for atopic dermatitis using structural equation modeling (SEM). The biomarkers identified were latent variables, which are complex and derived from the abundance data for bacterial marker candidates. Groups of females and males classified as healthy participants [normal control (NC) (female: 321 participants, male: 99 participants)], and patients afflicted with atopic dermatitis only [AS (female: 45 participants, male: 13 participants)], with atopic dermatitis and other diseases [AM (female: 75 participants, male: 34 participants)], and with other diseases but without atopic dermatitis [OD (female: 1,669 participants, male: 866 participants)] were used in this investigation. The candidate bacterial markers were identified by comparing the intestinal microbial community compositions between the NC and AS groups. In females, two latent variables (lv) were identified; for lv1, the associated components (bacterial genera) were Alistipes, Butyricimonas, and Coprobacter, while for lv2, the associated components were Agathobacter, Fusicatenibacter, and Streptococcus. There was a significant difference in the lv2 scores between the groups with atopic dermatitis (AS, AM) and those without (NC, OD), and the genera identified for lv2 are associated with the suppression of inflammatory responses in the body. A logistic regression model to estimate the probability of atopic dermatitis morbidity with lv2 as an explanatory variable had an area under the curve (AUC) score of 0.66 when assessed using receiver operating characteristic (ROC) analysis, and this was higher than that using other logistic regression models. The results indicate that the latent variables, especially lv2, could represent the effects of atopic dermatitis on the intestinal microbiome in females. The latent variables in the SEM could thus be utilized as a new type of biomarker. The advantages identified for the SEM are as follows: (1) it enables the extraction of more sophisticated information when compared with models focused on individual bacteria and (2) it can improve the accuracy of the latent variables used as biomarkers, as the SEM can be expanded. Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9909428/ /pubmed/36778866 http://dx.doi.org/10.3389/fmicb.2023.1035002 Text en Copyright © 2023 Tokuno, Itoga, Kasuga, Okuma, Hasuko, Masuyama and Benno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Tokuno, Hidetaka Itoga, Tatsuya Kasuga, Jumpei Okuma, Kana Hasuko, Kazumi Masuyama, Hiroaki Benno, Yoshimi Method for estimating disease risk from microbiome data using structural equation modeling |
title | Method for estimating disease risk from microbiome data using structural equation modeling |
title_full | Method for estimating disease risk from microbiome data using structural equation modeling |
title_fullStr | Method for estimating disease risk from microbiome data using structural equation modeling |
title_full_unstemmed | Method for estimating disease risk from microbiome data using structural equation modeling |
title_short | Method for estimating disease risk from microbiome data using structural equation modeling |
title_sort | method for estimating disease risk from microbiome data using structural equation modeling |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909428/ https://www.ncbi.nlm.nih.gov/pubmed/36778866 http://dx.doi.org/10.3389/fmicb.2023.1035002 |
work_keys_str_mv | AT tokunohidetaka methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT itogatatsuya methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT kasugajumpei methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT okumakana methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT hasukokazumi methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT masuyamahiroaki methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling AT bennoyoshimi methodforestimatingdiseaseriskfrommicrobiomedatausingstructuralequationmodeling |